Question 1

What are the specific doses and schedules for Nivolumab and Daratumumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread clinical trial (NCT03098550). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread clinical trial (NCT03098550). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this combination treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread clinical trial (NCT03098550). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread clinical trial (NCT03098550). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if my cancer does not respond to this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread clinical trial (NCT03098550). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures involved in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread clinical trial (NCT03098550). Contact the study team or your healthcare provider for specific answers.

What this study is about